Bosentan
Payments companies reported to CMS as associated with Bosentan. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Bosentan, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Bosentan
These are the largest totals companies reported as associated with Bosentan. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Raymond Benza | Norfolk, VA | Advanced Heart Failure and Transplant Cardiology | $97.77 |
| Mohsen Noreldin | Westborough, MA | Pulmonary Disease | $64.66 |
| Corey Saltin | Leominster, MA | Pulmonary Disease | $25.89 |
| Erica Altschul | New York, NY | Pulmonary Disease | $17.52 |
| Jonathan Moore | Phoenix, AZ | Pulmonary Disease | $17.52 |
| Fernando Torres | Dallas, TX | Pulmonary Disease | $14.49 |
| Charlotte Lipsky | Los Angeles, CA | Acute Care (Nurse Practitioner) | $14.13 |
| Ai Jin Lee | Los Angeles, CA | Clinical Nurse Specialist | $14.13 |
| Jonathan Danaraj | Spokane, WA | Pulmonary Disease | $12.85 |
| Arsalan Shirwany | Memphis, TN | Interventional Cardiology | $12.19 |
Prescribed Bosentan?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.